The Brookline Brief
Our Monthly Insight into U.S. Healthcare Equity Markets
Undeterred by a host of potential macroeconomic headwinds – ranging from a near-term “tapering” by the Federal Reserve of its ongoing bond-buying programs to the frustrating and increasingly disruptive resilience of the novel SARS nCoV-2 coronavirus in the US and around the globe – US equities nevertheless capped off the finale to Summer 2021 on a high note, with major indices like the Dow, NASDAQ, and Russell 2000 each climbing higher by +1.2%, +4.0%, and +2.1%, respectively, over the past month.
